CALL/ABBOTT LABORATORIES/160/0.1/17.01.25 Share Price

Warrant

DE000GQ9GJT2

Real-time BOERSE MUENCHEN 11:25:12 23/05/2024 BST
0.017 EUR -22.73% Intraday chart for CALL/ABBOTT LABORATORIES/160/0.1/17.01.25
Current month+4.76%
1 month-12.00%
Date Price Change
23/05/24 0.017 -22.73%
22/05/24 0.022 +15.79%
21/05/24 0.019 +18.75%
20/05/24 0.016 -23.81%
17/05/24 0.021 -16.00%

Real-time BOERSE MUENCHEN

Last update May 23, 2024 at 11:25 am

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying ABBOTT LABORATORIES
Issuer Goldman Sachs
WKN GQ9GJT
ISINDE000GQ9GJT2
Date issued 19/02/2024
Strike 160 $
Maturity 17/01/2025 (240 Days)
Parity 10 : 1
Emission price 0.02
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 0.071
Lowest since issue 0.013
Spread 0.03
Spread %63.83%

Company Profile

Abbott Laboratories specializes in the research, development, manufacturing and marketing of pharmaceutical and medical products. Net sales break down by family of products as follows: - diagnostic systems and instruments (39.1%); - vascular devices (24.7%): endoprosthetic systems, dilation catheters, arterial closures, etc.; - nutrition products (12.1%): pediatric nutrition products, nutritional supplements, and dietetic products; - medicine (8.2%): anesthetics, antiviral products, antibiotics, inhibitors, anti-inflammatories, etc.; - other (15.9%). Net sales are distributed geographically as follows: the United States (38.5%), Germany (5.8%), China (5.6%), India (4.4%), Switzerland (4.1%), Japan (3.8%), Netherlands (2.7%) and others (35.1%).
Sector
-
More about the company

Ratings for Abbott Laboratories

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Abbott Laboratories

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
23
Last Close Price
104.8 USD
Average target price
125.7 USD
Spread / Average Target
+19.91%
Consensus